What do "none," "mild," "moderate," "severe," and "very severe" mean to patients with cancer? Content validity of PRO-CTCAE™ response scales Journal Article
| Authors: | Atkinson, T. M.; Hay, J. L.; Dueck, A. C.; Mitchell, S. A.; Mendoza, T. R.; Rogak, L. J.; Minasian, L. M.; Basch, E. |
| Article Title: | What do "none," "mild," "moderate," "severe," and "very severe" mean to patients with cancer? Content validity of PRO-CTCAE™ response scales |
| Keywords: | major clinical study; clinical trial; letter; quality of life; neuropathy; cancer therapy; anxiety; patient-reported outcome; human; male; female; malignant neoplasm; patient reported outcomes version of the common terminology criteria for adverse |
| Journal Title: | Journal of Pain and Symptom Management |
| Volume: | 55 |
| Issue: | 3 |
| ISSN: | 0885-3924 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-03-01 |
| Start Page: | e3 |
| End Page: | e6 |
| Language: | English |
| DOI: | 10.1016/j.jpainsymman.2017.10.024 |
| PROVIDER: | scopus |
| PUBMED: | 29129739 |
| PMCID: | PMC6317851 |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 2 April 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work